Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
A phase 3 trial of Cytarabine, Daunorubicin, Vincristine, Dexamethasone, Methotrexate, Cyclophosphamide, Mercaptopurine, Rituximab, Doxorubicin, Thioguanine and Inotuzumab ozogamicin in Acute lymphoblastic leukaemia, run by Alliance for Clinical Trials in Oncology, now recruiting.
Overview
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia is a phase 3 interventional study registered as NCT03150693 by Alliance for Clinical Trials in Oncology, with 303 participants planned, started 2017-09-20 and due to reach its primary completion in 2027-03-01. Interventions recorded: Allopurinol, Cytarabine, Daunorubicin Hydrochloride, Vincristine Sulfate, Dexamethasone, Pegylated L-Asparaginase, Methotrexate, Bone Marrow Aspiration and Biopsy, Cyclophosphamide, Mercaptopurine, Rituximab, Doxorubicin, Thioguanine, Inotuzumab Ozogamicin, Laboratory Biomarker Analysis. Conditions recorded: B Acute Lymphoblastic Leukemia.
Linked to the drug Mercaptopurine because the registry names it among its interventions and Acute lymphoblastic leukaemia among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialInternational Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia
Shares Thioguanine, Mercaptopurine, Daunorubicin, Cytarabine and the tag pipeline.
- TrialCombination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
Shares Thioguanine, Mercaptopurine, Daunorubicin, Cytarabine and the tag pipeline.
- TrialCombination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Shares Mercaptopurine, Daunorubicin, Cytarabine, Methotrexate and the tag pipeline.
- TrialTherapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma
Shares Mercaptopurine, Cytarabine, Methotrexate, Dexamethasone and the tag pipeline.
- TrialRituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
Shares Cytarabine, Methotrexate, Vincristine, Rituximab and the tag pipeline.
- TrialTreatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
Shares Cytarabine, Methotrexate, Dexamethasone, Vincristine and the tag pipeline.
- TrialTreatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
Shares Daunorubicin, Cytarabine, Dexamethasone, Vincristine and the tag pipeline.
- TrialSafety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
Shares Cytarabine, Methotrexate, Dexamethasone, Vincristine and the tag pipeline.